Literature DB >> 18726055

Antibody testing as a diagnostic tool in autonomic disorders.

Steven Vernino1.   

Abstract

Some forms of peripheral autonomic dysfunction (especially enteric neuropathy and subacute panautonomic failure) occur as autoimmune phenomena either in isolation or in the context of cancer. Autoimmune autonomic ganglionopathy is an example of a severe, but potentially treatable, antibody-mediated form of autonomic failure. Diagnostic evaluation of autonomic disorders can be supplemented by testing for paraneoplastic antibodies and antibodies against membrane receptors. The diagnostic antibodies most commonly associated with dysautonomia are paraneoplastic antibodies (anti-Hu and CRMP-5) and ganglionic acetylcholine receptor antibodies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18726055     DOI: 10.1007/s10286-008-0488-6

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  43 in total

1.  Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes.

Authors:  J Honnorat; T Byk; I Kusters; M Aguera; D Ricard; V Rogemond; T Quach; D Aunis; A Sobel; M G Mattei; P Kolattukudy; M F Belin; J C Antoine
Journal:  Eur J Neurosci       Date:  1999-12       Impact factor: 3.386

2.  Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice.

Authors:  P A Sillevis Smitt; G T Manley; J B Posner
Journal:  Neurology       Date:  1995-10       Impact factor: 9.910

3.  CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.

Authors:  Z Yu; T J Kryzer; G E Griesmann; K Kim; E E Benarroch; V A Lennon
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

4.  Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction.

Authors:  J S Chinn; M D Schuffler
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

5.  Thymoma-associated neuromyotonia with antibodies against voltage-gated potassium channels presenting as chronic intestinal pseudo-obstruction.

Authors:  Jean-François Viallard; Angela Vincent; Jean-François Moreau; Marie Parrens; Jean-Luc Pellegrin; Emmanuel Ellie
Journal:  Eur Neurol       Date:  2005-03-07       Impact factor: 1.710

6.  Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review.

Authors:  J Newsom-Davis; K R Mills
Journal:  Brain       Date:  1993-04       Impact factor: 13.501

7.  Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis.

Authors:  Nicholas D Lawn; Barbara F Westmoreland; Michael J Kiely; Vanda A Lennon; Steven Vernino
Journal:  Mayo Clin Proc       Date:  2003-11       Impact factor: 7.616

8.  Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current.

Authors:  Z Wang; P A Low; J Jordan; R Freeman; C H Gibbons; C Schroeder; P Sandroni; S Vernino
Journal:  Neurology       Date:  2007-05-29       Impact factor: 9.910

9.  FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.

Authors:  S Younes-Mhenni; M F Janier; L Cinotti; J C Antoine; F Tronc; V Cottin; P J Ternamian; P Trouillas; J Honnorat
Journal:  Brain       Date:  2004-09-10       Impact factor: 13.501

10.  The Lambert-Eaton myasthenic syndrome. A review of 50 cases.

Authors:  J H O'Neill; N M Murray; J Newsom-Davis
Journal:  Brain       Date:  1988-06       Impact factor: 13.501

View more
  5 in total

1.  Autoimmune autonomic neuropathies: time to look beyond autoimmune autonomic ganglionopathy.

Authors:  Srikanth Muppidi
Journal:  Clin Auton Res       Date:  2018-01-05       Impact factor: 4.435

Review 2.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

Review 3.  Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances.

Authors:  Elisabeth P Golden; Steven Vernino
Journal:  Clin Auton Res       Date:  2019-05-15       Impact factor: 4.435

4.  Autoimmune channelopathies of the nervous system.

Authors:  Kleopas A Kleopa
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

Review 5.  Identification of technology frontiers of artificial intelligence-assisted pathology based on patent citation network.

Authors:  Ting Zhang; Juan Chen; Yan Lu; Xiaoyi Yang; Zhaolian Ouyang
Journal:  PLoS One       Date:  2022-08-22       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.